Recent Advances in the Discovery of CK2 Inhibitors

Mustafa A. Al-Qadhi,Tawfeek A. A. Yahya,Hala B. El-Nassan

DOI: https://doi.org/10.1021/acsomega.3c10478

IF: 4.1

2024-05-21

ACS Omega

Abstract:CK2 is a vital enzyme that phosphorylates a large number of substrates and thereby controls many processes in the body. Its upregulation was reported in many cancer types. Inhibitors of CK2 might have anticancer activity, and two compounds are currently under clinical trials. However, both compounds are ATP-competitive inhibitors that may have off-target side effects. The development of allosteric and dual inhibitors can overcome this drawback. These inhibitors showed higher selectivity and...

chemistry, multidisciplinary